Search

everythinglearnresearchcommunity

for

Search:↓

Interleukin levels are higher in alopecia areata patients but don't predict disease severity or duration.

COVID-19 patients may experience hair loss, but it's not linked to their age or sex.

Taking finasteride can partially improve oxygen levels in hospitalized male patients over 50 with COVID-19 pneumonia, but it doesn't affect other outcomes like death rate or hospital stay length.

Certain genetic differences may affect how likely someone is to get COVID-19 and how severe it might be.

Histopathology is not reliable for detecting early fibrosis in traction alopecia or for showing how severe it is.

Midscalp hair density and terminal hair percentage are good indicators of female pattern hair loss severity.

Higher CD70 and CD27 gene expression in alopecia areata lesions predicts disease severity and activity.

Lower hair copper and copper-to-zinc ratio are linked to more severe coronary artery disease.

Having PCOS does not make hidradenitis suppurativa worse.

People with lower levels of free testosterone tend to have worse COVID-19 outcomes.

Higher levels of retinol-binding protein 4 are found in people with alopecia areata, but these levels don't relate to how severe the condition is.

People with severe hair loss have higher levels of a protein called interleukin 17 in their blood.

Oxidative stress may worsen female pattern hair loss and could help track the disease and treatment.

PFD patch helps laser tattoo removal, trichoscopy diagnoses AGA, and serum boosts SOD activity.

Men with higher body mass index (BMI) in Taiwan tend to have more severe hair loss.

Long-term use of dutasteride for enlarged prostate may worsen blood sugar, cholesterol, and erectile dysfunction.

Finasteride worsens erectile dysfunction and lowers testosterone in men with enlarged prostates, unlike tamsulosin.

Blood tests can help understand the genetic differences in people with alopecia areata, including how severe it is and if it's inherited.

Higher MIF levels in alopecia areata patients suggest it could be a treatment target and disease predictor.

A specific gene mutation in Japanese people can cause varying degrees of hair thinning in adulthood.

Higher antigliadin antibodies are linked to more severe alopecia areata, suggesting screening for celiac disease in these patients.

Combining scalp photos with hair density and caliber measurements gives a more accurate assessment of hair loss.

Hidradenitis suppurativa is a chronic skin condition more common in women, linked to genetics and lifestyle factors, and associated with various other health issues.

Higher GPER-1 levels are linked to more severe and shorter-duration androgenetic alopecia, suggesting GPER-1 as a potential treatment target.

More effective treatments are needed for severe alopecia areata.

Higher levels of CCL7 are linked to more severe hair loss in alopecia areata patients.

The document concludes that a new system using the SALT score should replace the current alopecia areata classification for better accuracy in assessing severity and prognosis.

People with alopecia areata often have lower vitamin D levels, which may be linked to the condition's severity.